Interchange Capital Partners LLC decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 11.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,234 shares of the company’s stock after selling 405 shares during the period. Interchange Capital Partners LLC’s holdings in Procter & Gamble were worth $544,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. NewSquare Capital LLC lifted its holdings in Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company’s stock valued at $26,000 after purchasing an additional 140 shares in the last quarter. RPg Family Wealth Advisory LLC purchased a new position in Procter & Gamble in the 3rd quarter valued at $33,000. LFA Lugano Financial Advisors SA purchased a new position in Procter & Gamble in the 4th quarter valued at $34,000. Atlantic Private Wealth LLC lifted its holdings in Procter & Gamble by 95.3% in the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company’s stock valued at $35,000 after purchasing an additional 101 shares in the last quarter. Finally, Noble Wealth Management PBC acquired a new stake in shares of Procter & Gamble in the 4th quarter worth $39,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have issued reports on PG shares. Stifel Nicolaus raised their target price on Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Erste Group Bank raised Procter & Gamble from a “hold” rating to a “strong-buy” rating in a research report on Monday, March 17th. Barclays raised their price objective on Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 23rd. Piper Sandler lowered their target price on Procter & Gamble from $173.00 to $172.00 and set a “neutral” rating for the company in a report on Monday, February 24th. Finally, Wells Fargo & Company raised their target price on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a report on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $181.47.
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 35,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the transaction, the chief executive officer now owns 22,051 shares of the company’s stock, valued at $3,829,817.68. The trade was a 61.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 90,450 shares of Procter & Gamble stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the transaction, the insider now directly owns 172,814 shares in the company, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 143,450 shares of company stock worth $23,988,008 over the last 90 days. 0.18% of the stock is owned by insiders.
Procter & Gamble Stock Performance
Shares of PG opened at $166.60 on Monday. The stock has a 50-day simple moving average of $167.97 and a 200-day simple moving average of $169.65. The stock has a market capitalization of $390.66 billion, a PE ratio of 26.53, a PEG ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $153.52 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $21.88 billion during the quarter, compared to analysts’ expectations of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.84 earnings per share. On average, analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.42%. The ex-dividend date of this dividend was Friday, January 24th. Procter & Gamble’s payout ratio is 64.01%.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 ETFs to Ride the VIX Surge During Market Volatility
- 3 Healthcare Dividend Stocks to Buy
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.